Marieke van Son

101 MRI-GUIDED ULTRAFOCAL SALVAGE HDR-BRACHYTHERAPY 15. Peters M, Maenhout M, van der Voort van Zyp JR, et al. Focal salvage iodine- 125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 2014; 112(1): 77-82. 16. Ganzer R, Arthanareeswaran VKA, Ahmed HU, et al. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position state- ment. Prostate cancer and prostatic diseases 2018; 21(2): 175-86. 17. Steele EM, Holmes JA. A review of sal- vage treatment options for disease pro- gression after radiation therapy for lo- calized prostate cancer. Urol Oncol 2019. 18. Mbeutcha A, Chauveinc L, Bondiau PY, et al. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiation oncology (London, England) 2017; 12(1): 49. 19. Li YH, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS. Salvage focal prostate cryoablation for locally recur- rent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. The Prostate 2015; 75(1): 1-7. 20. Akin O, Gultekin DH, Vargas HA, et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent pros- tate cancer after radiation treatment: preliminary results. European radiology 2011; 21(9): 1970-8. 21. van der Poel H, Grivas N, van Leeuwen P, Heijmink S, Schoots I. The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer. World journal of urology 2019; 37(8): 1485-90. 22. Luzurier A, Jouve De Guibert PH, Allera A, et al. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Lim- ited added value for readers of varying level of experience. Journal of magnetic resonance imaging : JMRI 2018; 48(4): 1012-23. 23. Arumainayagam N, Kumaar S, Ahmed HU, et al. Accuracy of multiparametric magnetic resonance imaging in de- tecting recurrent prostate cancer after radiotherapy. BJU international 2010; 106(7): 991-7. 24. Zattoni F, Kawashima A, Morlacco A, et al. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multipara- metric 3T magnetic resonance imaging with endorectal coil. Practical radiation oncology 2017; 7(1): 42-9. 25. Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of Hybrid (6)(8)Ga-PSMA Ligand PET/CT in 248 Patients with Bio- chemical Recurrence After Radical Pros- tatectomy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015; 56(5): 668-74. 26. Jilg CA, Drendel V, Rischke HC, et al. Di- agnostic Accuracy of Ga-68-HBED-CC- PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer. Theranostics 2017; 7(6): 1770-80. 27. Abufaraj M, Grubmuller B, Zeitlinger M, et al. Prospective evaluation of the per- formance of [(68)Ga]Ga-PSMA-11 PET/ CT(MRI) for lymph node staging in pa- tients undergoing superextended sal- vage lymph node dissection after rad- ical prostatectomy. European journal of nuclear medicine and molecular imaging 2019; 46(10): 2169-77. 28. Priester A, Natarajan S, Khoshnoodi P, et al. Magnetic Resonance Imaging Un- derestimation of Prostate Cancer Ge- ometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. The Journal of urology 2017; 197(2): 320-6. 5